API and ingredient sourcing
Active ingredients and excipients come from concentrated, opaque supplier networks — a single disruption halts production lines.
Client Focus · CIS Pharma
Pharma already lives under audit: GxP, qualified suppliers, validated data. CIS Pharma extends that discipline to sustainability and supply-chain compliance — API sourcing, human rights due diligence and emissions — with the traceability regulators and auditors expect.
Where the risk concentrates
Active ingredients and excipients come from concentrated, opaque supplier networks — a single disruption halts production lines.
GxP qualification, CSRD, CSDDD and EU GMP inspections each demand their own evidence — usually collected repeatedly, by hand.
Temperature-controlled logistics and climate exposure translate directly into product loss and patient risk.
How CIS supports you
Versioned, approved, traceable documentation — one evidence base reused across GxP, ESG and customer audits.
Questionnaires, certifications and due diligence tracked per supplier, with gaps flagged and follow-ups automated.
Concentration, geography and climate hazards scored per supplier and site — before they become stock-outs.